Andrew L. Lux

Andrew L. Lux appears in our data through filings on AtriCure, Inc. shares, published by SEC (Form 4). We count 28 filings; the first trade dates from 15 February 2012 and the latest from 30 June 2017.

On the open market, the record shows 1 purchase worth €6,439 and 2 sales worth €438k. Netting one side against the other leaves €432k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 24 share grants and 1 option exercise. So far in 2017, the count stands at no purchases and 1 sale.

Most recently, on 5 July 2017, the filings show a share grant worth €14k in AtriCure, Inc. The last purchase on record was published on 24 January 2014, which is 4,672 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.